The primary outcome was the proportion of children aged 0-23months with up-to-date vaccination for BCG, OPV, Pentavalent 3, PCV, measles and yellow fever appropriate for age.

The secondary outcomes were the proportion of children with timely Pentavalent and measles vaccination, the proportion of children who had Pentavalent 1 but not Pentavalent 3 of those who were old enough (target age plus two weeks), trend in the number of children with measles and deaths from the target disease, and trend in ANC, delivery and out-patient attendance from three years prior to the intervention. We defined timely vaccination as receiving the scheduled vaccination no more than two weeks late following Clark and Sanderson, 2009 [12].

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.